Karch, H, et al.
The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak. EMBO Molecular Medicine
2012; 4: 841–848.
Rasko, DA, et al.
Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. New England Journal of Medicine
2011; 365: 709–717.
Hebbelstrup, Jensen B, et al.
Epidemiology and clinical manifestations of enteroaggregative Escherichia coli
. Clinical Microbiology Reviews
2014; 27: 614–630.
Frank, C, et al.
Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. New England Journal of Medicine
2011; 365: 1771–1780.
Werber, D, et al.
Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011. American Journal of Epidemiology
2013; 178: 984–992.
Gasser, C, et al.
Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia [in German]. Schweizerische Medizinische Wochenschrift
1955; 85: 905–909.
Akashi, S, et al.
A severe outbreak of haemorrhagic colitis and haemolytic uraemic syndrome associated with Escherichia coli O157:H7 in Japan. European Journal of Pediatrics
1994; 153: 650–655.
Michino, H, et al.
Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts [see comments]. American Journal of Epidemiology 11999; 150: 787–796.
Fukushima, H, et al.
Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996. Pediatrics International
1999; 41: 213–217.
Okajima, S. An outline of 1996 outbreak related with STEC O157 infection in Sakai City. Sakai City committee report of STEC O157 outbreak in Japan, 1997.
Dundas, S, et al.
The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clinical Infectious Diseases
2001; 33: 923–931.
Endo, Y, et al.
Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. European Journal of Biochemistry
1988; 171: 45–50.
Lingwood, CA, et al.
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. Journal of Biological Chemistry
1987; 262: 8834–8839.
Mangeney, M, et al.
Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Research
1993; 53: 5314–5319.
Ohyama, C, et al.
Immunohistochemical study of globotriaosyl ceramide (Gb3) in testicular tumors [in Japanese]. Nippon Hinyokika Gakkai Zasshi
1993; 84: 1308–1315.
Yokobayashi, K, et al.
Prospective cohort study of fever incidence and risk in elderly persons living at home. BMJ Open
2014; 4: e004998.
Scheiring, J, Andreoli, SP, Zimmerhackl, LB. Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatric Nephrology
2008; 23: 1749–1760.
Chaisri, U, et al.
Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome. Microbial Pathogenesis
2001; 31: 59–67.
Uchida, H, et al.
The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome. Pediatric research
1999; 45: 133–137.
Yamada, Y, et al.
Brainstem mechanisms of autonomic dysfunction in encephalopathy-associated Shiga toxin 2 intoxication. Annals of Neurology
1999; 45: 716–723.
Rooney, JC, Anderson, RM, Hopkins, IJ. Clinical and pathological aspects of central nervous system involvement in the haemolytic uraemic syndrome. Australian Paediatrc Journal
1971; 7: 28–33.
Siegler, RL. The hemolytic uremic syndrome. Pediatric Clinics of North America
1995; 42: 1505–1529.
Upadhyaya, K, et al.
The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics
1980; 65: 115–120.
Ikeda, K, et al.
Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection. Clinical Nephrology
1999; 52: 357–362.
Ikeda, K, et al.
Predictors for the development of haemolytic uraemic syndrome with Escherichia coli O157:H7 infections: with focus on the day of illness. Epidemiology and Infection
2000; 124: 343–349.
Su, C, Brandt, LJ.
Escherichia coli O157:H7 infection in humans. Annals of Internal Medicine
1995; 123: 698–714.
Rangel, JM, et al.
Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982–2002. Emerging Infectious Diseases
2005; 11: 603–609.
Rowe, PC, et al.
Haemolytic anaemia after childhood Escherichia coli O157:H7 infection: are females at increased risk?
Epidemiology and Infection
1991; 106: 523–530.